Retrospective identification and characterization of mild cognitive impairment from a prospective population cohort

American Journal of Geriatric Psychiatry

Volumn 18, Issue 8, 2010, Pages 692-700

  Ritchie, Karen ^a,b,f   Ancelin, Marie Laure ^a,b   Beaino, Ephrem ^a   Portet, Florence ^a,b   Brickman, Adam M ^c   Dartigues, Jean François ^a,d   Tzourio, Christophe ^a,e   Dupuy, Anne Marie ^a,b   Ritchie, Craig W ^f   Berr, Claudine ^a,b   Artero, Sylvaine ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

ApoE; cardiovascular disorder; cohort studies; dementia; diagnosis; gender; MCI

Indexed keywords

APOLIPOPROTEIN E4;

ADL DISABILITY; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BODY MASS; CLASSIFICATION ALGORITHM; COGNITION; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; RETROSPECTIVE STUDY; SEX DIFFERENCE; STROKE; SYMPTOMATOLOGY; TASK PERFORMANCE; WHITE MATTER;

EID: 77955171489     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181df4897     Document Type: Article

References (32)

1. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308
2. Busse A, Bischkopf J, Riedel-Heller SG, et al: Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand 2003; 108:71-81
3. Fisk JD, Merry HR, Rockwood K: Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003; 61:1179-1184
4. Lopez OL, Jagust WJ, Dulberg C, et al: Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003; 60:1394-1399
5. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56:37-42
6. Fischer P, Jungwirth S, Zehetmayer S, et al: Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007; 68:288-291
7. Manly JJ, Bell-McGinty S, Tang MX, et al: Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 2005; 62:1739-1746
8. Palmer K, Bäckman L, Winblad B, et al: Mild cognitive impairment in the general population: occurrence and progression to Alzheimer's disease. Am J Geriatr Psychiatry 2008; 16:603-611
9. Jack CR Jr, Petersen RC, Xu YC, et al: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52:1397-1403
10. Price JL, Morris JC: Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999; 45:358-368
11. La Rue A, Jarvik LF: Cognitive function and prediction of dementia in old age. Int J Ageing Hum Dev 1987; 25:79-89
12. The 3CStudyGroup. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003; 22:316-325
13. Lawton MP. Scales to measure competence in everyday activities. Psychopharmacol Bull 1988; 24:609-614
14. Ancelin ML, Artero S, Portet F, et al: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332:455-459
15. Radloff L: The CES-D Scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401
16. Reitan R: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1965; 8:271-276
17. Dubois B: L'épreuve des cinq mots. Neurologie-Psychiatrie- Géria-trie 2001; 1:40-42
18. Benton A: Manuel pour l'application du test de rétention visuelle. Applications cliniques et expérimentales. Paris: Centre de Psy-chologie Appliquée, 1965
19. Isaacs B, Kennie AT: The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973; 123:467-470
20. Gurol ME, Irizarry MC, Smith EE, et al: Plasma beta-amyloid and white matter lesions in AD, MCI and cerebral amyloid angiopathy. Neurology 2006; 66:23-29
21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association, 1994
22. Winblad B, Palmer K, Kivipelto M, et al: Mild cognitive impair-ment\beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256:240-246
23. Artero S, Ancelin ML, Portet F, et al: Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008; 79:979-984
24. Romero JR, Beiser A, Seshadri S, et al: Carotid artery atherosclerosis, MRI indices of brain ischemia, aging and cognitive impairment: the Framingham study. Stroke 2009; 40:1590-1596
25. Targosz-Gajniak M, Siuda J, Ochudlo S, et al: Cerebral white matter lesions in patients with dementia\from MCI to severe Alzheimer's disease. J Neurol Sci 2009; 283:79-82
26. Debette S, Bombois S, Bruandet A, et al: Subcortical hyperinten-sities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007; 38:2924-2930
27. Avila-Funes J, Helmer C, Amieva H, et al: Frailty among community dwelling elderly people in France. J Gerontol 2008; 63:1089-1096
28. Forsell Y, Palmer K, Fratiglioni L: Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment. Data from a cross-sectional study. Acta Neurol Scand Suppl 2003; 179:25-28
29. Lavretsky H, Siddarth P, Kepe V, et al: Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. Am J Geriatr Psychiatry 2009; 17:493-502
30. Linn RT, Wolf PA, Bachman DL, et al: The preclinical phase of probable Alzheimer's disease. A 13 year prospective study of the Framingham cohort. Arch Neurol 1995; 52:485-490
31. Jak AJ, Delano-Wood L, Wierenga C, et al: Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry 2009; 17:368-375
32. Loewenstein DA, Acevedo A, Ownby R, et al: Using different memory cutoffs to assess mild cognitive impairment. Am J Geriatr Psychiatry 2006; 14:911-919